Mouse salivary glands and human β-defensin-2 as a study model for antimicrobial gene therapy: technical considerations

International Journal of Antimicrobial Agents

Volumn 28, Issue 4, 2006, Pages 352-360

  Yin, Chunyi ^a   Dang, Hoa N ^a,b   Gazor, Farzad ^a   Huang, George T J ^a  

^a UCLA SCHOOL OF DENTISTRY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Candida albicans; hBD 2; Lentiviral vectors; Mouse salivary glands; SCID mice

Indexed keywords

BETA DEFENSIN 2; COMPLEMENTARY DNA; LENTIVIRUS VECTOR; POLYPEPTIDE ANTIBIOTIC AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANDIDA ALBICANS; CONTROLLED STUDY; DRUG POTENCY; ENZYME LINKED IMMUNOSORBENT ASSAY; FIBROSARCOMA; GASTROINTESTINAL TRACT; GENE OVEREXPRESSION; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; MOUSE STRAIN; MOUTH CAVITY; MYCOSIS; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SALIVA; SALIVARY GLAND; SCID MOUSE; SUBMANDIBULAR GLAND; THRUSH;

ANIMALS; ANTI-INFECTIVE AGENTS; BETA-DEFENSINS; CANDIDA ALBICANS; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; GENE THERAPY; HUMANS; MICE; MICE, INBRED NOD; MICE, SCID; MOUTH MUCOSA; RETROVIRIDAE; SALIVA; SALIVARY DUCTS;

EID: 33748744782     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2006.08.003     Document Type: Article

References (45)

1. Bals R., Weiner D.J., Moscioni A.D., Meegalla R.L., and Wilson J.M. Augmentation of innate host defense by expression of a cathelicidin antimicrobial peptide. Infect Immun 67 (1999) 6084-6089
2. O'Connell B.C., Xu T., Walsh T.J., et al. Transfer of a gene encoding the anticandidal protein histatin 3 to salivary glands. Hum Gene Ther 7 (1996) 2255-2261
3. Yarus S., Rosen J.M., Cole A.M., and Diamond G. Production of active bovine tracheal antimicrobial peptide in milk of transgenic mice. Proc Natl Acad Sci USA 93 (1996) 14118-14121
4. Bals R., Weiner D.J., Meegalla R.L., and Wilson J.M. Transfer of a cathelicidin peptide antibiotic gene restores bacterial killing in a cystic fibrosis xenograft model. J Clin Invest 103 (1999) 1113-1117
5. Bals R., Xiao W., Sang N., Weiner D.J., Meegalla R.L., and Wilson J.M. Transduction of well-differentiated airway epithelium by recombinant adeno-associated virus is limited by vector entry. J Virol 73 (1999) 6085-6088
6. Liu A.Y., Destoumieux D., Wong A.V., et al. Human beta-defensin-2 production in keratinocytes is regulated by interleukin-1, bacteria, and the state of differentiation. J Invest Dermatol 118 (2002) 275-281
7. Garcia J.R., Krause A., Schulz S., et al. Human beta-defensin 4: a novel inducible peptide with a specific salt-sensitive spectrum of antimicrobial activity. FASEB J 15 (2001) 1819-1821
8. Carretero M., Del Rio M., Garcia M., et al. A cutaneous gene therapy approach to treat infection through keratinocyte-targeted overexpression of antimicrobial peptides. FASEB J 18 (2004) 1931-1933
9. Huang G.T., Zhang H.B., Kim D., Liu L., and Ganz T. A model for antimicrobial gene therapy: demonstration of human beta-defensin 2 antimicrobial activities in vivo. Hum Gene Ther 13 (2002) 2017-2025
10. Yang D., Biragyn A., Hoover D.M., Lubkowski J., and Oppenheim J.J. Multiple roles of antimicrobial defensins, cathelicidins, and eosinophil-derived neurotoxin in host defense. Annu Rev Immunol 22 (2004) 181-215
11. Quinones-Mateu M.E., Lederman M.M., Feng Z., et al. Human epithelial beta-defensins 2 and 3 inhibit HIV-1 replication. AIDS 17 (2003) F39-F48
12. Sawamura D., Goto M., Shibaki A., et al. Beta defensin-3 engineered epidermis shows highly protective effect for bacterial infection. Gene Ther 12 (2005) 857-861
13. Sun L., Finnegan C.M., Kish-Catalone T., et al. Human beta-defensins suppress human immunodeficiency virus infection: potential role in mucosal protection. J Virol 79 (2005) 14318-14329
14. Jia H.P., Schutte B.C., Schudy A., et al. Discovery of new human beta-defensins using a genomics-based approach. Gene 263 (2001) 211-218
15. Schutte B.C., Mitros J.P., Bartlett J.A., et al. Discovery of five conserved beta-defensin gene clusters using a computational search strategy. Proc Natl Acad Sci USA 99 (2002) 2129-2133
16. Premratanachai P., Joly S., Johnson G.K., McCray Jr. P.B., Jia H.P., and Guthmiller J.M. Expression and regulation of novel human beta-defensins in gingival keratinocytes. Oral Microbiol Immunol 19 (2004) 111-117
17. Yin C., Dang H.N., Zhang H.B., et al. Capacity of human beta-defensin expression in gene-transduced and cytokine-induced cells. Biochem Biophys Res Commun 339 (2006) 344-354
18. Huang G.T., Zhang H.B., Yin C., and Park S.H. Human beta-defensin-2 gene transduction of dental pulp cells: a model for pulp antimicrobial gene therapy. Int J Oral Biol 29 (2004) 7-12
19. Baum B.J., Voutetakis A., and Wang J. Salivary glands: novel target sites for gene therapeutics. Trends Mol Med 10 (2004) 585-590
20. Voutetakis A., Bossis I., Kok M.R., et al. Salivary glands as a potential gene transfer target for gene therapeutics of some monogenetic endocrine disorders. J Endocrinol 185 (2005) 363-372
21. Voutetakis A., Kok M.R., Zheng C., et al. Reengineered salivary glands are stable endogenous bioreactors for systemic gene therapeutics. Proc Natl Acad Sci USA 101 (2004) 3053-3058
22. Dale B.A., and Krisanaprakornkit S. Defensin antimicrobial peptides in the oral cavity. J Oral Pathol Med 30 (2001) 321-327
23. Dunsche A., Acil Y., Siebert R., Harder J., Schroder J.M., and Jepsen S. Expression profile of human defensins and antimicrobial proteins in oral tissues. J Oral Pathol Med 30 (2001) 154-158
24. Mathews M., Jia H.P., Guthmiller J.M., et al. Production of beta-defensin antimicrobial peptides by the oral mucosa and salivary glands. Infect Immun 67 (1999) 2740-2745
25. Abiko Y., Nishimura M., and Kaku T. Defensins in saliva and the salivary glands. Med Electron Microsc 36 (2003) 247-252
26. Mineshiba F., Takashiba S., Mineshiba J., Matsuura K., Kokeguchi S., and Murayama Y. Antibacterial activity of synthetic human B defensin-2 against periodontal bacteria. J Int Acad Periodontol 5 (2003) 35-40
27. Klotman M.E., and Chang T.L. Defensins in innate antiviral immunity. Nat Rev Immunol 6 (2006) 447-456
28. Niyonsaba F., Ogawa H., and Nagaoka I. Human beta-defensin-2 functions as a chemotactic agent for tumour necrosis factor-alpha-treated human neutrophils. Immunology 111 (2004) 273-281
29. Meitner S.W., Bowen W.H., and Haidaris C.G. Oral and esophageal Candida albicans infection in hyposalivatory rats. Infect Immun 58 (1990) 2228-2236
30. An D.S., Wersto R.P., Agricola B.A., et al. Marking and gene expression by a lentivirus vector in transplanted human and nonhuman primate CD34(+) cells. J Virol 74 (2000) 1286-1295
31. Kung S.K., An D.S., and Chen I.S. A murine leukemia virus (MuLV) long terminal repeat derived from rhesus macaques in the context of a lentivirus vector and MuLV gag sequence results in high-level gene expression in human T lymphocytes. J Virol 74 (2000) 3668-3681
32. Joly S., Maze C., McCray Jr. P.B., and Guthmiller J.M. Human beta-defensins 2 and 3 demonstrate strain-selective activity against oral microorganisms. J Clin Microbiol 42 (2004) 1024-1029
33. Schroder J.M., and Harder J. Human beta-defensin-2. Int J Biochem Cell Biol 31 (1999) 645-651
34. Bonass W.A., High A.S., Owen P.J., and Devine D.A. Expression of beta-defensin genes by human salivary glands. Oral Microbiol Immunol 14 (1999) 371-374
35. Sahasrabudhe K.S., Kimball J.R., Morton T.H., Weinberg A., and Dale B.A. Expression of the antimicrobial peptide, human beta-defensin 1, in duct cells of minor salivary glands and detection in saliva. J Dent Res 79 (2000) 1669-1674
36. Tanida T., Okamoto T., Okamoto A., et al. Decreased excretion of antimicrobial proteins and peptides in saliva of patients with oral candidiasis. J Oral Pathol Med 32 (2003) 586-594
37. Shai E., Falk H., Honigman A., Panet A., and Palmon A. Gene transfer mediated by different viral vectors following direct cannulation of mouse submandibular salivary glands. Eur J Oral Sci 110 (2002) 254-260
38. Shai E., Palmon A., Panet A., et al. Prolonged transgene expression in murine salivary glands following non-primate lentiviral vector transduction. Mol Ther 12 (2005) 137-143
39. Takakura N., Sato Y., Ishibashi H., et al. A novel murine model of oral candidiasis with local symptoms characteristic of oral thrush. Microbiol Immunol 47 (2003) 321-326
40. Clemons K.V., and Stevens D.A. Efficacy of ravuconazole in treatment of mucosal candidosis in SCID mice. Antimicrob Agents Chemother 45 (2001) 3433-3436
41. Farah C.S., Hong S., Wanasaengsakul S., et al. Irradiation-induced oral candidiasis in an experimental murine model. Oral Microbiol Immunol 16 (2001) 358-363
42. Takakura N., Wakabayashi H., Ishibashi H., et al. Oral lactoferrin treatment of experimental oral candidiasis in mice. Antimicrob Agents Chemother 47 (2003) 2619-2623
43. Sundstrom P., Balish E., and Allen C.M. Essential role of the Candida albicans transglutaminase substrate, hyphal wall protein 1, in lethal oroesophageal candidiasis in immunodeficient mice. J Infect Dis 185 (2002) 521-530
44. de Repentigny L., Aumont F., Ripeau J.S., et al. Mucosal candidiasis in transgenic mice expressing human immunodeficiency virus type 1. J Infect Dis 185 (2002) 1103-1114
45. Teichert M.C., Jones J.W., Usacheva M.N., and Biel M.A. Treatment of oral candidiasis with methylene blue-mediated photodynamic therapy in an immunodeficient murine model. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 93 (2002) 155-160